IRIS Accounts Production v24.3.2.46 06300338 director 1.8.23 31.7.24 31.7.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063003382023-07-31063003382024-07-31063003382023-08-012024-07-31063003382022-07-31063003382022-08-012023-07-31063003382023-07-3106300338ns15:EnglandWales2023-08-012024-07-3106300338ns14:PoundSterling2023-08-012024-07-3106300338ns10:Director12023-08-012024-07-3106300338ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3106300338ns10:SmallEntities2023-08-012024-07-3106300338ns10:AuditExemptWithAccountantsReport2023-08-012024-07-3106300338ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3106300338ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3106300338ns10:FullAccounts2023-08-012024-07-310630033812023-08-012024-07-3106300338ns10:OrdinaryShareClass12023-08-012024-07-3106300338ns10:CompanySecretary12023-08-012024-07-3106300338ns10:RegisteredOffice2023-08-012024-07-3106300338ns5:CurrentFinancialInstruments2024-07-3106300338ns5:CurrentFinancialInstruments2023-07-3106300338ns5:ShareCapital2024-07-3106300338ns5:ShareCapital2023-07-3106300338ns5:RetainedEarningsAccumulatedLosses2024-07-3106300338ns5:RetainedEarningsAccumulatedLosses2023-07-3106300338ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3106300338ns5:PlantMachinery2023-08-012024-07-3106300338ns5:NetGoodwill2023-07-3106300338ns5:NetGoodwill2024-07-3106300338ns5:NetGoodwill2023-07-3106300338ns5:PlantMachinery2023-07-3106300338ns5:PlantMachinery2024-07-3106300338ns5:PlantMachinery2023-07-3106300338ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3106300338ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3106300338ns5:DeferredTaxation2023-07-3106300338ns5:DeferredTaxation2023-08-012024-07-3106300338ns5:DeferredTaxation2024-07-3106300338ns10:OrdinaryShareClass12024-07-31
REGISTERED NUMBER: 06300338 (England and Wales)















LONDON UROLOGY LIMITED

Unaudited Financial Statements for the Year Ended 31 July 2024






LONDON UROLOGY LIMITED (REGISTERED NUMBER: 06300338)

Contents of the Financial Statements
for the Year Ended 31 July 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 7

LONDON UROLOGY LIMITED

Company Information
for the Year Ended 31 July 2024







DIRECTOR: D F Badenoch





SECRETARY: Dr M P Badenoch





REGISTERED OFFICE: Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB





REGISTERED NUMBER: 06300338 (England and Wales)





ACCOUNTANTS: Lancaster Haskins Limited
Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB

LONDON UROLOGY LIMITED (REGISTERED NUMBER: 06300338)

Balance Sheet
31 July 2024

31.7.24 31.7.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 20,822 33,382
20,822 33,382

CURRENT ASSETS
Debtors 6 114,131 25,813
Cash at bank 1,121,314 1,228,565
1,235,445 1,254,378
CREDITORS
Amounts falling due within one year 7 58,272 51,816
NET CURRENT ASSETS 1,177,173 1,202,562
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,197,995

1,235,944

PROVISIONS FOR LIABILITIES 8 5,206 8,345
NET ASSETS 1,192,789 1,227,599

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 1,192,689 1,227,499
SHAREHOLDERS' FUNDS 1,192,789 1,227,599

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LONDON UROLOGY LIMITED (REGISTERED NUMBER: 06300338)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 3 March 2025 and were signed by:





D F Badenoch - Director


LONDON UROLOGY LIMITED (REGISTERED NUMBER: 06300338)

Notes to the Financial Statements
for the Year Ended 31 July 2024


1. STATUTORY INFORMATION

London Urology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is attributable to urological services and is recognised in line with services performed.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33.33% on cost and 25% on reducing balance

Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference shares or non-puttable ordinary shares which are measured at fair value, with changes
recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

LONDON UROLOGY LIMITED (REGISTERED NUMBER: 06300338)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 August 2023
and 31 July 2024 476,728
AMORTISATION
At 1 August 2023
and 31 July 2024 476,728
NET BOOK VALUE
At 31 July 2024 -
At 31 July 2023 -

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 August 2023
and 31 July 2024 78,258
DEPRECIATION
At 1 August 2023 44,876
Charge for year 12,560
At 31 July 2024 57,436
NET BOOK VALUE
At 31 July 2024 20,822
At 31 July 2023 33,382

LONDON UROLOGY LIMITED (REGISTERED NUMBER: 06300338)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors 23,980 24,389
Directors' current accounts 66,338 -
Tax 22,389 -
Prepayments 1,424 1,424
114,131 25,813

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Tax 53,456 -
Social security and other taxes 618 48,130
Other creditors - 802
Accrued expenses 4,198 2,884
58,272 51,816

8. PROVISIONS FOR LIABILITIES
31.7.24 31.7.23
£    £   
Deferred tax 5,206 8,345

Deferred
tax
£   
Balance at 1 August 2023 8,345
Credit to Income Statement during year (3,139 )
Balance at 31 July 2024 5,206

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
100 Ordinary £1 100 100

10. ULTIMATE CONTROLLING PARTY

The controlling party is M P Badenoch.

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
London Urology Limited


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of London Urology Limited for the year ended 31 July 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of London Urology Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of London Urology Limited and state those matters that we have agreed to state to the director of London Urology Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than London Urology Limited and its director for our work or for this report.

It is your duty to ensure that London Urology Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of London Urology Limited. You consider that London Urology Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of London Urology Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Lancaster Haskins Limited
Granville House
2 Tettenhall Road
Wolverhampton
West Midlands
WV1 4SB


5 March 2025